Enhanced survival from radiation pneumonitis by combined irradiation to the skin.

To develop mitigators for combined irradiation to the lung and skin.
Rats were treated with X-rays as follows: (1) 12.5 or 13 Gy whole thorax irradiation (WTI); (2) 30 Gy soft X-rays to 10% area of the skin only; (3) 12.5 or 13 Gy WTI + 30 Gy skin irradiation after 3 hours; (4) 12.5 Gy WTI + skin irradiation and treated with captopril (160 mg/m(2)/day) started after 7 days. Our end points were survival (primary) based on IACUC euthanization criteria and secondary measurements of breathing intervals and skin injury. Lung collagen at 210 days was measured in rats surviving 13 Gy WTI.
After 12.5 Gy WTI with or without skin irradiation, one rat (12.5 Gy WTI) was euthanized. Survival was less than 10% in rats receiving 13 Gy WTI, but was enhanced when combined with skin irradiation (p < 0.0001). Collagen content was increased at 210 days after 13 Gy WTI vs. 13 Gy WTI + 30 Gy skin irradiation (p < 0.05). Captopril improved radiation-dermatitis after 12.5 Gy WTI + 30 Gy skin irradiation (p = 0.008).
Radiation to the skin given 3 h after WTI mitigated morbidity during pneumonitis in rats. Captopril enhanced the rate of healing of radiation-dermatitis after combined irradiations to the thorax and skin.
AuthorsFeng Gao, Brian L Fish, Aniko Szabo, Ashley Schock, Jayashree Narayanan, Elizabeth R Jacobs, John E Moulder, Zelmira Lazarova, Meetha Medhora
JournalInternational journal of radiation biology (Int J Radiat Biol) Vol. 90 Issue 9 Pg. 753-61 (Sep 2014) ISSN: 1362-3095 [Electronic] England
PMID24827855 (Publication Type: Journal Article, Research Support, N.I.H., Extramural)
Chemical References
  • Collagen
  • Captopril
  • Animals
  • Captopril (therapeutic use)
  • Collagen (chemistry)
  • Female
  • Fibrosis
  • Lung (radiation effects)
  • Radiation Injuries
  • Radiation Injuries, Experimental (drug therapy, radiotherapy)
  • Radiation Pneumonitis (drug therapy, radiotherapy)
  • Rats
  • Skin (radiation effects)
  • Thorax (radiation effects)
  • Time Factors
  • Treatment Outcome
  • Wound Healing
  • X-Rays

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research network!

Choose Username:
Verify Password: